The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

BioN­Tech opens new plas­mid DNA man­u­fac­tur­ing fa­cil­i­ty in Ger­many

3 years ago
Pharma
Cell/Gene Tx

Man­u­fac­tur­ing roundup: Catal­ent caps off man­u­fac­tur­ing site in Bel­gium; Eu­roAPI restarts pro­duc­tion in Hun­gary

3 years ago
Cell/Gene Tx

Af­ter a busy year of build­outs, Ther­mo Fish­er sets plans for growth in 2023

3 years ago
Pharma

New com­peti­tors push Sanofi to of­fer vol­un­tary re­tire­ment pack­ages at two In­di­an sites

3 years ago
People
Pharma

Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

3 years ago
Financing
Startups

Charles Riv­er se­cures $50M ac­qui­si­tion of drug dis­cov­ery tech com­pa­ny

3 years ago
Deals

Bris­tol My­ers, Charles Riv­er join Se­ries A fund­ing for iVex­Sol

3 years ago
Financing
Pharma

Up­dat­ed: Sam­sung Bi­o­log­ics spells out ex­pan­sion plans in South Ko­rea and US

3 years ago
Pharma

FDA takes next step in Tor­rent Phar­ma­ceu­ti­cal­s' trou­bled In­dia plant saga, is­sues OAI

3 years ago
Pharma
FDA+

Man­u­fac­tur­ing roundup: AGC Bi­o­log­ics to man­u­fac­ture di­a­betes ther­a­py; Cam­brex caps ac­qui­si­tion of Snap­drag­on Chem­istry

3 years ago

Abzena lays off more than 60 em­ploy­ees in Cal­i­for­nia

3 years ago
People

Lon­za posts full 2022 re­sults as it looks to buy back $2B+ in shares

3 years ago
Pharma

Eli Lil­ly in­vests $450M to ex­pand its North Car­oli­na Re­search Tri­an­gle man­u­fac­tur­ing site

3 years ago
Financing

WHO push­es for ac­tion by man­u­fac­tur­ers and gov­ern­ments af­ter warn­ings over con­t­a­m­i­nat­ed cough syrups

3 years ago
Pharma

Man­u­fac­tur­ing roundup: FDA, Swissmedic ink deal on phar­ma GMP; SK biotech con­tracts with Charles Riv­er for RNA ther­a­py 

3 years ago

Small-cap CNS out­fit inks API deal for pre­clin­i­cal MEK in­hibitor

3 years ago
Deals

In­tas Phar­ma­ceu­ti­cals un­der FDA scruti­ny over 'cas­cade of fail­ure' in over­sight of GMP doc­u­ments

3 years ago
Pharma

In bid to ad­vance man­u­fac­tur­ing ca­pa­bil­i­ties, In­scrip­ta buys out two biotechs

3 years ago

Up­dat­ed: FDA slaps Op­tum In­fu­sion with a warn­ing let­ter over 'in­san­i­tary' pro­duc­tion con­di­tions

3 years ago
Pharma

Pfiz­er inks deal to snatch Abzena's new North Car­oli­na man­u­fac­tur­ing site

3 years ago

Three Ohio-based con­tract or­ga­ni­za­tions win $149M deal for neu­ro­log­i­cal can­di­dates

3 years ago
Deals
Outsourcing

Man­u­fac­tur­ing roundup: Cy­ti­va part­ners with Au­risco to build site for oligonu­cleotides; Eu­roAPI in­vest­ing €40M to boost pro­duc­tion

3 years ago

WHO is­sues alert over con­t­a­m­i­nat­ed cough syrups

3 years ago
Pharma

Con­tract man­u­fac­tur­er nets cap­i­tal in­vest­ment to ex­pand its phys­i­cal space and in­stall a new fill-fin­ish line

3 years ago
First page Previous page 37383940414243 Next page Last page
A service from the Financial Times